Abstract:Abstract SARS-CoV-2, the causative agent of COVID-19, emerged in Wuhan, China in December 2019 and spread rapidly throughout the world. Understanding the introductions of this new coronavirus in different settings may assist control efforts and the establishment of frameworks to support rapid response in future infectious disease outbreaks. We investigated the first four weeks of emergence of the SARS-CoV-2 virus in Scotland after the first case reported on the 1st March 2020. We obtained full genome sequences from 452 individuals with a laboratory-confirmed diagnosis of COVID-19, representing 20% of all cases until 1st April 2020 (n=2310). This permitted a genomic epidemiology approach to study the introductions and spread of the SARS-2 virus in Scotland. From combined phylogenetic and epidemiological analysis, we estimated at least 113 introductions of SARS-CoV-2 into Scotland during this period. Clusters containing multiple sequences suggestive of onward transmission occurred in 48/86 (56%). 42/86 (51%) clusters had no known international travel history indicating undetected introductions. The majority of viral sequences were most closely related to those circulating in other European countries, including Italy, Austria and Spain. Travel-associated introductions of SARS-CoV-2 into Scotland predated travel restrictions in the UK and other European countries. The first local transmission occurred three days after the first case. A shift from travel-associated to sustained community transmission was apparent after only 11 days. Undetected introductions occurred prior to the first known case of COVID-19. Earlier travel restrictions and quarantine measures might have resulted in fewer introductions into Scotland, thereby reducing the number of cases and the subsequent burden on health services. The high number of introductions and transmission rates were likely to have impacted on national contact tracing efforts. Our results also demonstrate that local real-time genomic epidemiology can be used to monitor transmission clusters and facilitate control efforts to restrict the spread of COVID-19. Funding MRC (MC UU 1201412), UKRI/Wellcome (COG-UK), Wellcome Trust Collaborator Award (206298/Z/17/Z – ARTIC Network; TCW Wellcome Trust Award 204802/Z/16/Z Research in context Evidence before this study Coronavirus disease-2019 (COVID-19) was first diagnosed in Scotland on the 1 st of March 2020 following the emergence of the causative severe acute respiratory system coronavirus 2 (SARS-CoV-2) virus in China in December 2019. During the first month of the outbreak in Scotland, 2310 positive cases of COVID-19 were detected, associated with 1832 hospital admissions, 207 intensive care admissions and 126 deaths. The number of introductions into Scotland and the source of those introductions was not known prior to this study. Added value of this study Using a combined phylogenetic and epidemiological approach following real-time next generation sequencing of 452 SARS-CoV-2 samples, it was estimated that the virus was introduced to Scotland on at least 113 occasions, mostly from other European countries, including Italy, Austria and Spain. Localised outbreaks occurred in the community across multiple Scottish health boards, within healthcare facilities and an international conference and community transmission was established rapidly, before local and international lockdown measures were introduced.

Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B. 1.1. 7 emergence

Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence

Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1

Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA. 1

Context-specific emergence and growth of the SARS-CoV-2 Delta variant

Molecular Phylogenesis and Spatiotemporal Spread of SARS-CoV-2 in Southeast Asia

SARS-CoV-2 European Resurgence Foretold: Interplay of Introductions and Persistence by Leveraging Genomic and Mobility Data

Tracking the international spread of SARS-CoV-2 lineages B. 1.1. 7 and B. 1.351/501Y-V2

Tracking the international spread of SARS-CoV-2 lineages B. 1.1. 7 and B. 1.351/501Y-V2 with grinch

Tracking the Molecular Evolution and Transmission Patterns of SARS-CoV-2 Lineage B.1.466.2 in Indonesia Based on Genomic Surveillance Data

Emergence of the B.1.214.2 SARS-CoV-2 lineage with an Omicron-like spike insertion and a unique upper airway immune signature

Transmission of SARS-CoV-2 Lineage B. 1.1. 7 in England: Insights from linking epidemiological and genetic data

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England

Genomic epidemiology of SARS-CoV-2 spread in Scotland highlights the role of European travel in COVID-19 emergence

Large-scale genomic analysis of SARS-CoV-2 Omicron BA.5 emergence in the United States

Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK

Revealing fine-scale spatiotemporal differences in SARS-CoV-2 introduction and spread

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

The emergence of SARS-CoV-2 in Europe and North America

Untangling Introductions and Persistence in COVID-19 Resurgence in Europe